Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Leonardi

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
MLO: Medical Laboratory Observer|August 19, 2015
Determining myocardial infarction after PCI: CK-MB, troponin, both, or neither?Pierluigi Tricoci, Sergio Leonardi
Heart (British Cardiac Society)|September 12, 2012
Peri-procedural myocardial infarction and troponism: a quick journey through the land of confusionMarco Valgimigli, Sergio Leonardi
European Heart Journal. Acute Cardiovascular Care|June 3, 2017
Practical considerations for cangrelor use in patients with acute coronary syndromesSergio Leonardi, Deepak L Bhatt
Handbook of Experimental Pharmacology|August 25, 2012
PAR-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with atherothrombosisSergio Leonardi, Richard C Becker
European Heart Journal|September 30, 2020
The future for the Acute Cardiovascular Care Congress we shall find togetherSergio Leonardi, Konstantin A Krychtiuk
Current Cardiology Reports|June 1, 2014
Cangrelor: review of the drug and the CHAMPION programme (including PHOENIX)Marcello Marino, Diego Rizzotti, Sergio Leonardi
Giornale Italiano Di Cardiologia (2006)|March 6, 2020
[Short dual antiplatelet therapy: how, when and why]Valentina Ditali, Chiara Carrozzi, Sergio Leonardi
Minerva Cardioangiologica|February 3, 2018
Parenteral antithrombotic therapy during primary percutaneous coronary interventionFederico Fortuni, Marco Ferlini, Sergio Leonardi
European Heart Journal|June 21, 2021
Around the clock, around the world-reflections on 24 hours of acute cardiovascular careKonstantin Alexander Krychtiuk, Christian Hassager, Sergio Leonardi
Advances in Cardiology|August 22, 2012
Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndromeSergio Leonardi, Pierluigi Tricoci, Richard C Becker
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
MLO: Medical Laboratory Observer|August 19, 2015
Determining myocardial infarction after PCI: CK-MB, troponin, both, or neither?Pierluigi Tricoci, Sergio Leonardi
Heart (British Cardiac Society)|September 12, 2012
Peri-procedural myocardial infarction and troponism: a quick journey through the land of confusionMarco Valgimigli, Sergio Leonardi
European Heart Journal. Acute Cardiovascular Care|June 3, 2017
Practical considerations for cangrelor use in patients with acute coronary syndromesSergio Leonardi, Deepak L Bhatt
Handbook of Experimental Pharmacology|August 25, 2012
PAR-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with atherothrombosisSergio Leonardi, Richard C Becker
European Heart Journal|September 30, 2020
The future for the Acute Cardiovascular Care Congress we shall find togetherSergio Leonardi, Konstantin A Krychtiuk
Current Cardiology Reports|June 1, 2014
Cangrelor: review of the drug and the CHAMPION programme (including PHOENIX)Marcello Marino, Diego Rizzotti, Sergio Leonardi
Giornale Italiano Di Cardiologia (2006)|March 6, 2020
[Short dual antiplatelet therapy: how, when and why]Valentina Ditali, Chiara Carrozzi, Sergio Leonardi
Minerva Cardioangiologica|February 3, 2018
Parenteral antithrombotic therapy during primary percutaneous coronary interventionFederico Fortuni, Marco Ferlini, Sergio Leonardi
European Heart Journal|June 21, 2021
Around the clock, around the world-reflections on 24 hours of acute cardiovascular careKonstantin Alexander Krychtiuk, Christian Hassager, Sergio Leonardi
Advances in Cardiology|August 22, 2012
Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndromeSergio Leonardi, Pierluigi Tricoci, Richard C Becker
Pageof 20